🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

35,89 USD

Máx. histórico

41,81

54 días

Caída desde máximo

-14,16%

Rango 52 semanas

19,30 – 42,50

Variación hoy

-2,76%

Cierre anterior

36,91

Rango de hoy

35,81 – 37,29

Volumen hoy

5.699.508

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,49%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 1 día
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/11/2025 20,28 20,72 20,08 20,56 +1,33% 3,13% 6.297.600
14/11/2025 20,00 21,17 19,98 20,29 -1,31% 5,95% 8.295.400
13/11/2025 21,07 21,23 20,54 20,56 -3,56% 3,30% 8.081.900
12/11/2025 20,94 21,33 20,83 21,32 +2,01% 2,39% 7.773.200
11/11/2025 21,27 21,27 20,49 20,90 -1,28% 3,64% 10.038.200
10/11/2025 20,16 21,35 19,79 21,17 +2,67% 7,74% 12.419.300
07/11/2025 20,40 20,77 19,96 20,62 +0,24% 3,97% 9.417.500
06/11/2025 20,10 20,69 20,03 20,57 +1,68% 3,26% 10.849.100
05/11/2025 19,83 20,30 19,62 20,23 +1,81% 3,45% 9.902.300
04/11/2025 19,33 19,89 19,32 19,87 +1,38% 2,98% 11.643.100
03/11/2025 19,88 20,03 19,30 19,60 -1,95% 3,70% 9.088.000
31/10/2025 19,61 20,09 19,39 19,99 +2,09% 3,57% 7.301.100
30/10/2025 18,87 19,67 18,73 19,58 +4,37% 4,95% 11.870.800
29/10/2025 18,36 18,91 18,32 18,76 +1,90% 3,21% 7.398.500
28/10/2025 18,81 18,96 18,32 18,41 -2,13% 3,38% 8.277.300
27/10/2025 18,31 18,86 18,27 18,81 +3,24% 3,19% 10.914.700
24/10/2025 18,13 18,34 17,89 18,22 +0,55% 2,48% 6.953.400
23/10/2025 18,00 18,42 17,91 18,12 +0,89% 2,83% 7.394.300
22/10/2025 17,81 17,98 17,64 17,96 +0,50% 1,91% 7.116.900
21/10/2025 17,65 17,93 17,54 17,87 +0,73% 2,18% 7.401.600
20/10/2025 17,31 18,06 17,28 17,74 +2,78% 4,51% 17.727.100
17/10/2025 17,11 17,33 16,88 17,26 +0,88% 2,60% 8.794.000
16/10/2025 17,04 17,28 16,89 17,11 +0,71% 2,26% 7.051.900
15/10/2025 16,55 17,13 16,41 16,99 +3,60% 4,35% 9.966.000
14/10/2025 16,11 16,78 16,00 16,40 +1,17% 4,84% 5.174.800
13/10/2025 16,17 16,28 15,99 16,21 +1,06% 1,79% 3.512.700
10/10/2025 16,12 16,22 15,90 16,04 -0,50% 1,99% 4.850.300
09/10/2025 16,00 16,39 15,99 16,12 +0,56% 2,53% 7.940.700
08/10/2025 16,20 16,34 15,96 16,03 -0,56% 2,35% 5.850.600
07/10/2025 16,22 16,40 15,25 16,12 -0,86% 7,09% 7.899.800